Literature DB >> 12775625

Medical journals and pharmaceutical companies: uneasy bedfellows.

Richard Smith1.   

Abstract

Keywords:  Bioethics and Professional Ethics; Biomedical and Behavioral Research; Health Care and Public Health

Mesh：

Year:  2003        PMID： 12775625      PMCID： PMC1126057          DOI： 10.1136/bmj.326.7400.1202

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Are randomised controlled trials in the BMJ different?

Authors:  M Egger; C Bartlett; P Jüni
Journal:  BMJ       Date:  2001-11-24

2.  Sponsorship, authorship, and accountability.

Authors:  F Davidoff; C D DeAngelis; J M Drazen; J Hoey; L Højgaard; R Horton; S Kotzin; M G Nicholls; M Nylenna; A J Overbeke; H C Sox; M B Van Der Weyden; M S Wilkes
Journal:  Lancet       Date:  2001-09-15       Impact factor: 79.321

3.  Congress criticises drugs industry for misleading advertising.

Authors:  Scott Gottlieb
Journal:  BMJ       Date:  2002-12-14

4.  Accuracy of pharmaceutical advertisements in medical journals.

Authors:  Pilar Villanueva; Salvador Peiró; Julián Librero; Inmaculada Pereiró
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

5.  Pharmaceutical advertisements in leading medical journals: experts' assessments.

Authors:  M S Wilkes; B H Doblin; M F Shapiro
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

6.  A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis.

Authors:  P A Rochon; J H Gurwitz; R W Simms; P R Fortin; D T Felson; K L Minaker; T C Chalmers
Journal:  Arch Intern Med       Date:  1994-01-24

7.  The quality of drug studies published in symposium proceedings.

Authors:  M K Cho; L A Bero
Journal:  Ann Intern Med       Date:  1996-03-01       Impact factor: 25.391

8.  Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal.

Authors:  P A Rochon; J H Gurwitz; C M Cheung; J A Hayes; T C Chalmers
Journal:  JAMA       Date:  1994-07-13       Impact factor: 56.272
  8 in total
  20 in total

1.  Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2003-05-31

2.  No more free lunches.

Authors:  Kamran Abbasi; Richard Smith
Journal:  BMJ       Date:  2003-05-31

3.  Lessons from the withdrawal of rofecoxib.

Authors:  Paul A Dieppe; Shah Ebrahim; Richard M Martin; Peter Jüni
Journal:  BMJ       Date:  2004-10-16

4.  The teaching of drug development to medical students: collaboration between the pharmaceutical industry and medical school.

Authors:  A G Stanley; D Jackson; D B Barnett
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

5.  Pharmaceutical advertisements in medical journals received in a medical clinic: are we having "too much of a good thing"?

Authors:  Sapna Lohiya
Journal:  J Natl Med Assoc       Date:  2005-05       Impact factor: 1.798

6.  Commercial influence and the content of medical journals.

Authors:  Joel Lexchin; Donald W Light
Journal:  BMJ       Date:  2006-06-17

Review 7.  The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Authors:  Gisela Schott; Henry Pachl; Ulrich Limbach; Ursula Gundert-Remy; Klaus Lieb; Wolf-Dieter Ludwig
Journal:  Dtsch Arztebl Int       Date:  2010-04-30       Impact factor: 5.594

Review 8.  Quality of reporting of randomized controlled trials published in Intensive Care Medicine from 2001 to 2010.

Authors:  Nicola Latronico; Marta Metelli; Maddalena Turin; Simone Piva; Frank A Rasulo; Cosetta Minelli
Journal:  Intensive Care Med       Date:  2013-06-07       Impact factor: 17.440

9.  An open challenge. Open access and the challenges for scientific publishing.

Authors:  Xavier Bosch
Journal:  EMBO Rep       Date:  2008-05       Impact factor: 8.807

10.  Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study.

Authors:  Andreas Lundh; Marija Barbateskovic; Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  PLoS Med       Date:  2010-10-26       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.